HDAC8 and hepatocellular carcinoma: The aberrant overexpression of HDAC8 has been observed in various cancers, such as gastric cancer [16], hepatocellular carcinoma (HCC) [17], oral squamous cell carcinoma (OSCC) [18], and childhood acute lymphoblastic leukemia (ALL) [19].